Skip to main content
Log in

Hearing Loss in Patients with Inflammatory Bowel Disease

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background and Aims

Inflammatory bowel disease (IBD) has many characteristics of autoimmune diseases. Sensorineural hearing loss has been reported in many autoimmune diseases. Little is known about hearing loss in patients with IBD.

Methods

A prospective blinded comparative study was conducted over a 3-year period. IBD patients and controls underwent a complete otorhinolaryngeal examination and eudiometry test.

Results

Altogether 105 participants (76 patients and 29 controls) took part in this study. Mean age was 36, 51 % were males, and 40 % of the patients were presently hospitalized due to IBD exacerbation. Audiometric examination revealed that any hearing loss (mild to severe) was found in 29 (38 %) of the IBD population, compared to 4 (14 %) of the control group (p = 0.02). Extraintestinal manifestation (EIM) was present in 33/76 (43 %) of IBD patients. Any hearing loss and moderate to severe hearing loss were found in 17/33 (52 %) and 7/33 (21 %) in the EIM-positive group compared to 12/43 (28 %) and 4/43 (9 %) in the EIM-negative group (p = 0.036 and p = 0.14, respectively). Out of patients over the age of 40 with other EIMs, all 11/11 (100 %) of patients had any hearing loss compared to 8/12 (66 %) of patients over the age of 40 without other EIMs, p = 0.035.

Conclusions

Hearing loss may be another EIM of IBD. It is found in 38 % of IBD patients and in up to 52 % of patients with other EIMs and increases over the age of 40. Early hearing evaluation should be recommended to these high-risk IBD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54 e42; quiz e30.

  2. Xu XR, Liu CQ, Feng BS, Liu ZJ. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2014;20:3255–3264.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Shih DQ, Targan SR. Insights into IBD pathogenesis. Curr Gastroenterol Rep. 2009;11:473–480.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014;13:3–10.

    Article  CAS  PubMed  Google Scholar 

  5. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116–1122.

    Article  CAS  PubMed  Google Scholar 

  6. Hopkins DJ, Horan E, Burton IL, Clamp SE, de Dombal FT, Goligher JC. Ocular disorders in a series of 332 patients with Crohn’s disease. Br J Ophthalmol. 1974;58:732–737.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol. 1985;80:615–620.

    CAS  PubMed  Google Scholar 

  8. Rasmussen HH, Fallingborg J, Mortensen PB, et al. Primary sclerosing cholangitis in patients with ulcerative colitis. Scand J Gastroenterol. 1992;27:732–736.

    Article  CAS  PubMed  Google Scholar 

  9. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 2000;133:795–799.

    Article  CAS  PubMed  Google Scholar 

  10. Purrmann J, Zeidler H, Bertrams J, et al. HLA antigens in ankylosing spondylitis associated with Crohn’s disease. Increased frequency of the HLA phenotype B27, B44. J Rheumatol. 1988;15:1658–1661.

    CAS  PubMed  Google Scholar 

  11. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430–434.

    CAS  PubMed  Google Scholar 

  12. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltim). 1976;55:401–412.

    Article  CAS  Google Scholar 

  13. Lidar M, Carmel E, Kronenberg Y, Langevitz P. Hearing loss as the presenting feature of systemic vasculitis. Ann N Y Acad Sci. 2007;1107:136–141.

    Article  PubMed  Google Scholar 

  14. Abbasi M, Yazdi Z, Kazemifar AM, Bakhsh ZZ. Hearing loss in patients with systemic lupus erythematosus. Glob J Health Sci. 2013;5:102–106.

    PubMed  PubMed Central  Google Scholar 

  15. Lin C, Lin SW, Weng SF, Lin YS. Risk of sudden sensorineural hearing loss in patients with systemic lupus erythematosus: a population-based cohort study. Audiol Neurootol. 2013;18:95–100.

    Article  PubMed  Google Scholar 

  16. Smith KA, Yunker WK. Kawasaki disease is associated with sensorineural hearing loss: a systematic review. Int J Pediatr Otorhinolaryngol. 2014;78:1216–1220.

    Article  PubMed  Google Scholar 

  17. Bakthavachalam S, Driver MS, Cox C, Spiegel JH, Grundfast KM, Merkel PA. Hearing loss in Wegener’s granulomatosis. Otol Neurotol. 2004;25:833–837.

    Article  PubMed  Google Scholar 

  18. Magaro M, Zoli A, Altomonte L, et al. Sensorineural hearing loss in rheumatoid arthritis. Clin Exp Rheumatol. 1990;8:487–490.

    CAS  PubMed  Google Scholar 

  19. Vavricka SR, Greuter T, Scharl M, et al. Cogan’s syndrome in patients with inflammatory bowel disease—a case series. J Crohn’s Colitis. 2015;9:886–890.

    Article  Google Scholar 

  20. Ruckenstein MJ. Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg. 2004;12:426–430.

    Article  PubMed  Google Scholar 

  21. Yazici S, Benbir G, Ince B. Sensorineural hearing loss and status epilepticus associated with ulcerative colitis: is there enough evidence to support immune-related mechanisms? J Neurosci Rural Pract. 2015;6:77–79.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Nemoto H, Iguchi H, Ichikawa Y, Wakata N, Kurihara T. Ulcerative colitis presenting as sensorineural deafness, brainstem encephalopathy, and white matter lesions. Neurologist. 2004;10:165–168.

    Article  PubMed  Google Scholar 

  23. Kanra G, Kara A, Secmeer G, et al. Sensorineural hearing loss as an extra-intestinal manifestation of ulcerative colitis in an adolescent girl with pyoderma gangrenosum. Eur J Pediatr. 2002;161:216–218.

    Article  PubMed  Google Scholar 

  24. Kumar BN, Walsh RM, Wilson PS, Carlin WV. Sensorineural hearing loss and ulcerative colitis. J Laryngol Otol. 1997;111:277–278.

    CAS  PubMed  Google Scholar 

  25. Jacob A, Ledingham JG, Kerr AI, Ford MJ. Ulcerative colitis and giant cell arteritis associated with sensorineural deafness. J Laryngol Otol. 1990;104:889–890.

    Article  CAS  PubMed  Google Scholar 

  26. Bachmeyer C, Leclerc-Landgraf N, Laurette F, et al. Acute autoimmune sensorineural hearing loss associated with Crohn’s disease. Am J Gastroenterol. 1998;93:2565–2567.

    Article  CAS  PubMed  Google Scholar 

  27. Summers RW, Harker L. Ulcerative colitis and sensorineural hearing loss: is there a relationship? J Clin Gastroenterol. 1982;4:251–252.

    Article  CAS  PubMed  Google Scholar 

  28. Hollanders D. Sensorineural deafness—a new complication of ulcerative colitis? Postgrad Med J. 1986;62:753–755.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Dowd A, Rees WD. Treatment of sensorineural deafness associated with ulcerative colitis. Br Med J (Clin Res Ed). 1987;295:26.

    Article  CAS  Google Scholar 

  30. Weber RS, Jenkins HA, Coker NJ. Sensorineural hearing loss associated with ulcerative colitis. A case report. Arch Otolaryngol. 1984;110:810–812.

    Article  CAS  PubMed  Google Scholar 

  31. Kariya S, Fukushima K, Kataoka Y, Tominaga S, Nishizaki K. Inner-ear obliteration in ulcerative colitis patients with sensorineural hearing loss. J Laryngol Otol. 2008;122:871–874.

    Article  CAS  PubMed  Google Scholar 

  32. Staecker H, Lefebvre P. Autoimmune sensorineural hearing loss improved by tumor necrosis factor-alpha blockade: a case report. Acta Otolaryngol. 2002;122:684–687.

    Article  CAS  PubMed  Google Scholar 

  33. Akbayir N, Calis AB, Alkim C, et al. Sensorineural hearing loss in patients with inflammatory bowel disease: a subclinical extraintestinal manifestation. Dig Dis Sci. 2005;50:1938–1945.

    Article  PubMed  Google Scholar 

  34. Kalyoncu D, Urganci N, Calis AB, Ozbal A. Sensorineural hearing loss in pediatric patients with inflammatory bowel disease. Dig Dis Sci. 2010;55:150–152.

    Article  PubMed  Google Scholar 

  35. Karmody CS, Valdez TA, Desai U, Blevins NH. Sensorineural hearing loss in patients with inflammatory bowel disease. Am J Otolaryngol. 2009;30:166–170.

    Article  PubMed  Google Scholar 

  36. Casella G, Corbetta D, Zolezzi M, et al. Symptomatic sensorineural hearing loss in patients with ulcerative colitis. Tech Coloproctol. 2015;19:729–731.

    Article  CAS  PubMed  Google Scholar 

  37. Goodall AF, Siddiq MA. Current understanding of the pathogenesis of autoimmune inner ear disease: a review. Clin Otolaryngol. 2015;40:412–419.

    Article  CAS  PubMed  Google Scholar 

  38. Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110–119.

    Article  PubMed  Google Scholar 

  39. Henry JA, Dennis KC, Schechter MA. General review of tinnitus: prevalence, mechanisms, effects, and management. J Speech Lang Hear Res. 2005;48:1204–1235.

    Article  PubMed  Google Scholar 

  40. Neuhauser HK, von Brevern M, Radtke A, et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology. 2005;65:898–904.

    Article  CAS  PubMed  Google Scholar 

Download references

Author contributions

Dr. Dov Wengrower was the principal investigator and study initiator and was responsible for the patient recruitment as well as data collection and analysis. Dr. Benjamin Koslowsky was responsible for writing the manuscript, collecting the data, performing the statistics, and helped recruit patients for the study. Dr. Uri Peleg was responsible for performing the hearing examinations and collecting data on the hearing test results in Shaare-Zedek Medical Center. Mrs. Betty Mazuz was responsible for patient coordination, explanations, and completion of the study in Shaare-Zedek Medical Center. Dr. Leore Cohen was responsible for data collection and analyzing the data throughout the study. Dr. Menahem Gross was responsible for performing the hearing examinations and collecting data on the hearing test results in Hadassah Medical Center. Prof. Eran Goldin was responsible for patient recruitment and study supervision. Dr. Chanan Shaul was the principal otolaryngologist in the study and performed interpretation and data collection and supervision of the study. Mrs. Chana Jacobson is thanked for collaborating our study.

Funding

This work was funded by the Mirsky Foundation in Shaare-Zedek Medical Center, Jerusalem, Israel

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Benjamin Koslowsky.

Ethics declarations

Conflict of interest

There was no conflict of interest by any of the authors.

Additional information

Dov Wengrower and Benjamin Koslowsky contributed equally to this study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 58 kb)

Supplementary material 2 (DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wengrower, D., Koslowsky, B., Peleg, U. et al. Hearing Loss in Patients with Inflammatory Bowel Disease. Dig Dis Sci 61, 2027–2032 (2016). https://doi.org/10.1007/s10620-016-4074-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4074-9

Keywords

Navigation